Von dem Buch Successes and Limitations of Targeted Cancer Therapy haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Stahel: Successes and Limitations of Targeted Cancer Therapy (ISBN: 9783318025422) 2014, Erstausgabe, in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
83%: Edited By Solange Peters And Rolf A. Stahel.: Successes Limitations of Targeted Cancer Therapy (Progress in Tumor Research, Vol. 41) (ISBN: 9783318025415) 2014, in Deutsch, Broschiert.Nur diese Ausgabe anzeigen…
Successes and Limitations of Targeted Cancer Therapy
10 Angebote vergleichen
Bester Preis: € 137,40 (vom 23.04.2019)1
Successes and Limitations of Targeted Cancer Therapy (Progress in Tumor Research) (2014)
EN NW FE EB DLISBN: 9783318025422 bzw. 3318025429, in Englisch, 118 Seiten, S. Karger, neu, Erstausgabe, E-Book, elektronischer Download.
Lieferung aus: Deutschland, E-Book zum Download, Versandkostenfrei.
The treatment of patients with advanced malignancies has undergone remarkable change in the last few years. While in the past decisions about systemic therapy were largely based on the performance status of a patient, oncologists today also take into account the pathological and molecular characteristics of the patient’s tumor. Targeting specific molecular pathways important for tumorigenesis has become the preferred way of treatment for many types of malignancies. With these advances come new challenges including the optimization of therapy, recognizing and dealing with side effects and, importantly, the development of resistance. This book provides an up-to-date overview of the advances and limitations of targeted therapy for several tumor entities including breast cancer, colon cancer, gastrointestinal stromal tumors, lung cancer, melanoma, ovarian cancer and renal cell carcinoma. Written by over a dozen internationally renowned scientists, the book is suitable for advanced students, postdoctoral researchers, scientists and clinicians who wish to update their knowledge of the latest approaches to targeted cancer therapies. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: S. Karger, S. Karger, Produktgruppe: eBooks, Publiziert: 2014-02-19, Freigegeben: 2014-02-19, Studio: S. Karger.
The treatment of patients with advanced malignancies has undergone remarkable change in the last few years. While in the past decisions about systemic therapy were largely based on the performance status of a patient, oncologists today also take into account the pathological and molecular characteristics of the patient’s tumor. Targeting specific molecular pathways important for tumorigenesis has become the preferred way of treatment for many types of malignancies. With these advances come new challenges including the optimization of therapy, recognizing and dealing with side effects and, importantly, the development of resistance. This book provides an up-to-date overview of the advances and limitations of targeted therapy for several tumor entities including breast cancer, colon cancer, gastrointestinal stromal tumors, lung cancer, melanoma, ovarian cancer and renal cell carcinoma. Written by over a dozen internationally renowned scientists, the book is suitable for advanced students, postdoctoral researchers, scientists and clinicians who wish to update their knowledge of the latest approaches to targeted cancer therapies. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: S. Karger, S. Karger, Produktgruppe: eBooks, Publiziert: 2014-02-19, Freigegeben: 2014-02-19, Studio: S. Karger.
2
Successes and Limitations of Targeted Cancer Therapy
~EN NW EB DLISBN: 9783318025422 bzw. 3318025429, vermutlich in Englisch, S. Karger, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Versandkostenfrei.
Successes and Limitations of Targeted Cancer Therapy: The treatment of patients with advanced malignancies has undergone remarkable change in the last few years. While in the past decisions about systemic therapy were largely based on the performance status of a patient, oncologists today also take into account the pathological and molecular characteristics of the patient`s tumor. Targeting specific molecular pathways important for tumorigenesis has become the preferred way of treatment for many types of malignancies. With these advances come new challenges including the optimization of therapy, recognizing and dealing with side effects and, importantly, the development of resistance. This book provides an up-to-date overview of the advances and limitations of targeted therapy for several tumor entities including breast cancer, colon cancer, gastrointestinal stromal tumors, lung cancer, melanoma, ovarian cancer and renal cell carcinoma. Written by over a dozen internationally renowned scientists, the book is suitable for advanced students, postdoctoral researchers, scientists and clinicians who wish to update their knowledge of the latest approaches to targeted cancer therapies. Englisch, Ebook.
Successes and Limitations of Targeted Cancer Therapy: The treatment of patients with advanced malignancies has undergone remarkable change in the last few years. While in the past decisions about systemic therapy were largely based on the performance status of a patient, oncologists today also take into account the pathological and molecular characteristics of the patient`s tumor. Targeting specific molecular pathways important for tumorigenesis has become the preferred way of treatment for many types of malignancies. With these advances come new challenges including the optimization of therapy, recognizing and dealing with side effects and, importantly, the development of resistance. This book provides an up-to-date overview of the advances and limitations of targeted therapy for several tumor entities including breast cancer, colon cancer, gastrointestinal stromal tumors, lung cancer, melanoma, ovarian cancer and renal cell carcinoma. Written by over a dozen internationally renowned scientists, the book is suitable for advanced students, postdoctoral researchers, scientists and clinicians who wish to update their knowledge of the latest approaches to targeted cancer therapies. Englisch, Ebook.
3
Successes and Limitations of Targeted Cancer Therapy (2014)
EN NW EB DLISBN: 9783318025422 bzw. 3318025429, in Englisch, S. Karger, S. Karger, S. Karger, neu, E-Book, elektronischer Download.
Lieferung aus: Kanada, in-stock.
The treatment of patients with advanced malignancies has undergone remarkable change in the last few years. While in the past decisions about systemic therapy were largely based on the performance status of a patient, oncologists today also take into account the pathological and molecular characteristics of the patient's tumor. Targeting specific molecular pathways important for tumorigenesis has become the preferred way of treatment for many types of malignancies. With these advances come new challenges including the optimization of therapy, recognizing and dealing with side effects and, importantly, the development of resistance. This book provides an up-to-date overview of the advances and limitations of targeted therapy for several tumor entities including breast cancer, colon cancer, gastrointestinal stromal tumors, lung cancer, melanoma, ovarian cancer and renal cell carcinoma. Written by over a dozen internationally renowned scientists, the book is suitable for advanced students, postdoctoral researchers, scientists and clinicians who wish to update their knowledge of the latest approaches to targeted cancer therapies.
The treatment of patients with advanced malignancies has undergone remarkable change in the last few years. While in the past decisions about systemic therapy were largely based on the performance status of a patient, oncologists today also take into account the pathological and molecular characteristics of the patient's tumor. Targeting specific molecular pathways important for tumorigenesis has become the preferred way of treatment for many types of malignancies. With these advances come new challenges including the optimization of therapy, recognizing and dealing with side effects and, importantly, the development of resistance. This book provides an up-to-date overview of the advances and limitations of targeted therapy for several tumor entities including breast cancer, colon cancer, gastrointestinal stromal tumors, lung cancer, melanoma, ovarian cancer and renal cell carcinoma. Written by over a dozen internationally renowned scientists, the book is suitable for advanced students, postdoctoral researchers, scientists and clinicians who wish to update their knowledge of the latest approaches to targeted cancer therapies.
5
Successes and Limitations of Targeted Cancer Therapy (Progress in Tumor Research, Vol. 41) (2014)
DE HCISBN: 9783318025415 bzw. 3318025410, in Deutsch, S. Karger Publishing, gebundenes Buch.
Lieferung aus: Vereinigte Staaten von Amerika, Versandkostenfrei.
Von Händler/Antiquariat, Book Deals [60506629], Lewiston, NY, U.S.A.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, Book Deals [60506629], Lewiston, NY, U.S.A.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
6
Successes and Limitations of Targeted Cancer Therapy (2014)
DE NWISBN: 9783318025415 bzw. 3318025410, in Deutsch, Karger Verlag Feb 2014, neu.
Von Händler/Antiquariat, Rhein-Team Lörrach Ivano Narducci e.K. [57451429], Lörrach, BW, Germany.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
7
Successes and Limitations of Targeted Cancer Therapy (2014)
DE NWISBN: 9783318025415 bzw. 3318025410, in Deutsch, Karger Verlag Feb 2014, neu.
Von Händler/Antiquariat, AHA-BUCH GmbH [51283250], Einbeck, NDS, Germany.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
8
Successes and Limitations of Targeted Cancer Therapy (2014)
DE NWISBN: 9783318025415 bzw. 3318025410, in Deutsch, Karger Verlag Feb 2014, neu.
Von Händler/Antiquariat, Rheinberg-Buch [53870650], Bergisch Gladbach, NRW, Germany.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
9
Successes and Limitations of Targeted Cancer Therapy
DE NWISBN: 9783318025415 bzw. 3318025410, in Deutsch, Karger Verlag, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Versandbuchhandlung Kisch & Co. [3338288].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Versandbuchhandlung Kisch & Co. [3338288].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
10
Successes and Limitations of Targeted Cancer Therapy
~EN NW EBISBN: 9783318025422 bzw. 3318025429, vermutlich in Englisch, Karger, S. Inc. neu, E-Book.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…